miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome
M. Papadimitriou, Αριστέα-Μαρία Παπανώτα, Panagiotis G. Adamopoulos, Katerina‐Marina Pilala, Christine‐Ivy Liacos, Panagiotis Malandrakis, Nefeli Mavrianou‐Koutsoukou, Dimitrios Patseas, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Efstathios Kastritis, Margaritis Avgeris, Meletios Α. Dimopoulos, Evangelos Terpos, Andreas Scorilas
Topics & Concepts
MedicineInternal medicineOncologyMultiple myelomaCohortMonoclonal gammopathy of undetermined significanceDiseasemicroRNANomogramMonoclonalImmunologyBiologyMonoclonal antibodyAntibodyGeneBiochemistryMultiple Myeloma Research and TreatmentsMicroRNA in disease regulationChromosomal and Genetic Variations